Correct but do you want a multiplier of 3 applied to 5c or 10c?
Anyone paying a Premium for the Technology currently will be getting a bargain... Triple MC = 16.2c a share
9.5c in February ,, now with more cash and Positive Phase II Data, No Adverse Effects in the UK Parkinson Trial , New Formulation for the Skin Scaring SNT 9465 + 5,5c ......
If that is the last of PLatinum then the Company need to inform the market and why Platinum left the Building ,, not as a consequence of the Syntara Science but as a consequence of PLatinum Investors leaving their Fund.
Public Holiday her tomorrow, that's me for the Day .. be back Monday ,, lets hope that was the last of PLatinum and SNT management have received a wake up call that in non revenue Biotechs its the SH that pay the wages, and we expect a decent return on Capital especially when risk has been removed and Positive data 3 years in the making has just been delivered...
From the chart it looks like the Science fell flat and that's what Management need to rectify ASAFP
SNT Price at posting:
5.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)